Novel CWF19L1 mutations in patients with spinocerebellar ataxia, autosomal recessive 17

J Hum Genet. 2023 Dec;68(12):859-866. doi: 10.1038/s10038-023-01195-5. Epub 2023 Sep 26.


Spinocerebellar ataxia, autosomal recessive-17 (SCAR17) is a rare hereditary ataxia characterized by ataxic gait, cerebellar signs and occasionally accompanied by intellectual disability and seizures. Pathogenic mutations in the CWF19L1 gene that code for CWF19 like cell cycle control factor 1 cause SCAR17. We report here two unrelated families with the clinical characteristics of global developmental delay, cerebellar ataxia, pyramidal signs, and seizures. Cerebellar atrophy, and T2/FLAIR hypointense transverse pontine stripes were observed in brain imaging. Exome sequencing identified novel homozygous mutations including a splice acceptor site variant c.1375-2 A > G on intron 12 in a male patient and a single nucleotide variant c.452 T > G on exon 5 resulting in a missense variant p.Ile151Ser in the female patient from two unrelated families, respectively. Sanger sequencing confirmed the segregation of these variants in the family members with autosomal recessive inheritance. Transcript analysis of the splice site variant revealed activation of a novel cryptic splice acceptor site on exon 13 resulting in an alternative transcription with a loss of nine nucleotides on exon 13. Translation of this transcript predicted an in-frame deletion of three amino acids p.(459_461del). We also observed a novel exon 13 skipping which results in premature termination of the protein product. Our study expands the phenotype, radiological features, and genotypes known in SCAR17.

MeSH terms

  • Cerebellar Ataxia* / genetics
  • Female
  • Humans
  • Male
  • Mutation
  • Pedigree
  • RNA Splice Sites / genetics
  • Seizures / genetics
  • Spinocerebellar Ataxias* / diagnostic imaging
  • Spinocerebellar Ataxias* / genetics


  • RNA Splice Sites
  • CWF19L1 protein, human